camptothecin has been researched along with Eye Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Airoldi, G; Bassi, MT; Bonato, S; Bondioni, S; Bresolin, N; Cantoni, O; Clementi, E; Crimella, C; De Palma, C; Falcone, S; Grazia D'Angelo, M; Guidarelli, A; Panzeri, C; Tonelli, A; Vantaggiato, C | 1 |
| Chung, MK; Ha, CS; Kim, CY; Kim, JC; Kim, JK; Kim, SH; Lee, HS; Park, SC; Shin, DH; Son, WC; Suh, JE | 1 |
2 other study(ies) available for camptothecin and Eye Diseases
| Article | Year |
|---|---|
Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin.
Topics: Adult; Apoptosis; Apraxia, Ideomotor; Ataxia; Camptothecin; DNA Damage; DNA Helicases; Eye Diseases; Female; Homozygote; Humans; Hydrogen Peroxide; Male; Middle Aged; Mitomycin; Multifunctional Enzymes; Mutation; Pedigree; RNA Helicases | 2010 |
Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Cell Count; Body Weight; Camptothecin; Drinking; Eating; Eye Diseases; Female; Injections, Intravenous; Male; Organ Size; Rats; Rats, Sprague-Dawley; Topoisomerase I Inhibitors; Urinalysis | 2004 |